Abstract 18: Molecular dissection of chemotherapy response in triple negative breast cancer (TNBC) using microscaled proteogenomics
Meenakshi Anurag(Baylor College of Medicine), Matthew J. Ellis(Guardant (United States)), Eric J. Jaehnig(Baylor College of Medicine), Shankha Satpathy(Broad Institute), D.R. Mani(Broad Institute), Kristen Otte, Steven A. Carr(Broad Institute), Michael T. Lewis(Baylor College of Medicine), Karsten Krug(Broad Institute), Jonathan T. Lei(Baylor College of Medicine), Foluso O. Ademuyiwa(Washington University in St. Louis), Gloria V. Echeverria(Baylor College of Medicine), Yongchao Dou(Baylor College of Medicine), Michael A. Gillette(Broad Institute), Ana I. Robles(National Cancer Institute), Mothaffar F. Rimawi(Baylor College of Medicine), Henry Rodriguez(Cancer Clinic), Erik J. Bergstrom(Broad Institute), Bing Zhang(Baylor Genetics), Cathy Sullivan, Beom‐Jun Kim(Ulsan College), Ian S. Hagemann(Washington University in St. Louis)
Cited by 0
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k